February 2017 FDA Recall Drug by G & W Laboratories, Inc.
D-0519-2017 - CGMP Deviations

This Class III drug recall was voluntarily initiated by G & W Laboratories, Inc. on February 28, 2017 for the product Drug. The FDA reported the reason for recall as cgmp deviations. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0519-2017

Reason for Recall
CGMP Deviations: an expired active ingredient was used in the manufacture of these recalled lots.
Initiated
02-28-2017
Reported
03-22-2017
Quantity
39,816 bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
G & W Laboratories, Inc.
Nationwide in the USA.
Clindamycin Phosphate Topical Solution USP, 1%, packaged in a) 30 mL applicator bottles (NDC 0472-0987-91) and b) 60 mL applicator bottles (NDC 0472-0987-92), Rx Only, Manufactured by: G&W Laboratories, Inc., 111 Coolidge Street, South Plainfield, NJ 07080; Distributed by: Actavis Mid Atlantic LLC, 1877 Kawai Road, Lincolnton, NC 28092.

Batch or Lot Expiration Information

Lot# 's: a) 032100042, 032100043, 032100044, 032100045, Exp 06/17; b) 032100038, 032100039, 032100040, 032100041, Exp 05/17; 032100046, 032100047, 032100048, 032100049, Exp 06/17.